1. Home
  2. TFSL vs ELVN Comparison

TFSL vs ELVN Comparison

Compare TFSL & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

SELL

Current Price

$16.06

Market Cap

4.6B

Sector

Finance

ML Signal

SELL

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

SELL

Current Price

$46.88

Market Cap

4.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TFSL
ELVN
Founded
1938
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
4.2B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TFSL
ELVN
Price
$16.06
$46.88
Analyst Decision
Hold
Strong Buy
Analyst Count
2
14
Target Price
$18.00
★ $74.33
AVG Volume (30 Days)
673.9K
★ 1.4M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 7.81%
N/A
EPS Growth
★ 14.29
3.17
EPS
★ 0.27
N/A
Revenue
N/A
N/A
Revenue This Year
$7.65
N/A
Revenue Next Year
$2.84
N/A
P/E Ratio
$60.20
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.21
$14.79
52 Week High
$19.49
$62.32

Technical Indicators

Market Signals
Indicator
TFSL
ELVN
Relative Strength Index (RSI) 37.46 51.53
Support Level $16.04 $44.18
Resistance Level $16.20 $47.88
Average True Range (ATR) 0.32 2.28
MACD -0.03 0.31
Stochastic Oscillator 3.63 41.92

Price Performance

Historical Comparison
TFSL
ELVN

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: